Endogenous antigen presentation of MHC class II epitopes through non-autophagic pathways

被引:27
|
作者
Leung, Carol S. K. [1 ]
机构
[1] UCL, Inst Canc, Dept Haematol, London WC1E 6DD, England
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
基金
瑞士国家科学基金会;
关键词
antigen presentation; MHC class II molecules; endogenous presentation; intracellular antigens; non-classical pathways; RESTRICTED T-CELLS; SHOCK-PROTEIN; 90; INVARIANT CHAIN; TUMOR-ANTIGEN; PROCESSING PATHWAYS; CROSS-PRESENTATION; PEPTIDE COMPLEXES; DENDRITIC CELLS; IN-VIVO; MOLECULES;
D O I
10.3389/fimmu.2015.00464
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigenic peptides presented by major histocompatibility complex (MHC) class II molecules are generally derived from exogenous proteins acquired by antigen presenting cells. However, in some circumstances, MHC class II molecules can present intracellular proteins expressed within the antigen-presenting cells. There are several described pathways by which endogenous antigens are degraded and gain access to MHC class II molecules. These include autophagy and other non-autophagic pathways; the latter category includes the MHC class I-like pathways, heat shock protein 90-mediated pathways, and internalization from the plasma membrane. This review will summarize and discuss the non-autophagic pathways.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] ENDOGENOUS ANTIGEN PRESENTATION BY MHC CLASS-II MOLECULES
    SANT, AJ
    IMMUNOLOGIC RESEARCH, 1994, 13 (04) : 253 - 267
  • [2] Autophagy in MHC Class II Presentation of Endogenous Antigens
    Gannage, Monique
    Muenz, Christian
    AUTOPHAGY IN INFECTION AND IMMUNITY, 2009, 335 : 123 - 140
  • [3] Routes to manipulate MHC class II antigen presentation
    van den Hoorn, Tineke
    Paul, Petra
    Jongsma, Marlieke L. M.
    Neefjes, Jacques
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (01) : 88 - 95
  • [4] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Neefjes, Jacques
    Jongsma, Marlieke L. M.
    Paul, Petra
    Bakke, Oddmund
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (12) : 823 - 836
  • [5] Mechanisms of endogenous MHC class II presentation by tumor cells
    Chai, Jian-Guo
    IMMUNOTHERAPY, 2012, 4 (08) : 777 - 779
  • [6] Antigen presentation by MHC class II molecules
    Weenink, SM
    Gautam, AM
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (01) : 69 - 81
  • [7] HIGH-EFFICIENCY OF ENDOGENOUS ANTIGEN PRESENTATION BY MHC CLASS-II MOLECULES
    CALINLAURENS, V
    FORQUET, F
    LOMBARDPLATET, S
    BERTOLINO, P
    CHRETIEN, I
    TRESCOLBIEMONT, MC
    GERLIER, D
    RABOURDINCOMBE, C
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (10) : 1113 - 1121
  • [8] Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells
    Han, Shinha
    Kim, Kwanghee
    Song, Youngcheon
    Kim, Hyunyul
    Kwon, Jeunghak
    Lee, Young-Hee
    Lee, Chong-Kil
    Lee, Sang-Jin
    Ha, Namjoo
    Kim, Kyungjae
    ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (03) : 370 - 376
  • [9] Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells
    Shinha Han
    Kwanghee Kim
    Youngcheon Song
    Hyunyul Kim
    Jeunghak Kwon
    Young-Hee Lee
    Chong-Kil Lee
    Sang-Jin Lee
    Namjoo Ha
    Kyungjae Kim
    Archives of Pharmacal Research, 2008, 31 : 370 - 376
  • [10] Endosomally Stored MHC Class II Does Not Contribute to Antigen Presentation by Dendritic Cells at Inflammatory Conditions
    ten Broeke, Toine
    van Niel, Guillaume
    Wauben, Marca H. M.
    Wubbolts, Richard
    Stoorvogel, Willem
    TRAFFIC, 2011, 12 (08) : 1025 - 1036